Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large B-Cell, Diffuse | 12 | 2024 | 1403 | 2.360 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 15 | 2024 | 1628 | 1.580 |
Why?
|
Lymphoma, Follicular | 3 | 2022 | 453 | 1.040 |
Why?
|
Antibodies, Bispecific | 2 | 2022 | 191 | 0.840 |
Why?
|
Immunotherapy, Adoptive | 11 | 2024 | 1454 | 0.820 |
Why?
|
Antigens, CD19 | 7 | 2023 | 424 | 0.750 |
Why?
|
Mucin-1 | 6 | 2017 | 539 | 0.570 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2023 | 2536 | 0.570 |
Why?
|
Antineoplastic Agents | 9 | 2022 | 13630 | 0.570 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2015 | 693 | 0.490 |
Why?
|
Yttrium Radioisotopes | 1 | 2015 | 107 | 0.460 |
Why?
|
Vidarabine | 4 | 2024 | 336 | 0.440 |
Why?
|
Purines | 4 | 2021 | 605 | 0.420 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 13 | 2024 | 11712 | 0.410 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2020 | 264 | 0.370 |
Why?
|
Immunoglobulin A | 2 | 2012 | 979 | 0.370 |
Why?
|
Antibodies, Neoplasm | 1 | 2011 | 280 | 0.330 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2024 | 5649 | 0.320 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 2 | 2012 | 241 | 0.310 |
Why?
|
B-Lymphocytes | 2 | 2022 | 4742 | 0.310 |
Why?
|
Dendritic Cells | 3 | 2017 | 2725 | 0.300 |
Why?
|
Graft vs Host Disease | 4 | 2024 | 3025 | 0.280 |
Why?
|
Immunoglobulin M | 1 | 2012 | 1529 | 0.280 |
Why?
|
T-Lymphocytes | 9 | 2023 | 10181 | 0.280 |
Why?
|
Quinazolinones | 2 | 2019 | 223 | 0.260 |
Why?
|
Adenine | 5 | 2024 | 975 | 0.260 |
Why?
|
Thrombocytopenia | 4 | 2022 | 1174 | 0.260 |
Why?
|
Cyclophosphamide | 5 | 2024 | 2221 | 0.250 |
Why?
|
Lymphoma, B-Cell | 2 | 2022 | 935 | 0.240 |
Why?
|
Vaccination | 2 | 2016 | 3361 | 0.230 |
Why?
|
Remission Induction | 4 | 2021 | 2392 | 0.230 |
Why?
|
Multiple Myeloma | 4 | 2017 | 5130 | 0.230 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2017 | 209 | 0.230 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2018 | 419 | 0.220 |
Why?
|
Antigens, CD34 | 2 | 2024 | 653 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2803 | 0.220 |
Why?
|
Isoquinolines | 2 | 2021 | 353 | 0.210 |
Why?
|
Piperidines | 5 | 2024 | 1650 | 0.210 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2022 | 1375 | 0.210 |
Why?
|
Pyrazoles | 5 | 2020 | 1999 | 0.210 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2023 | 3602 | 0.200 |
Why?
|
Antibodies, Monoclonal | 4 | 2016 | 9185 | 0.200 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2023 | 221 | 0.190 |
Why?
|
Neutropenia | 2 | 2024 | 884 | 0.190 |
Why?
|
Cryptosporidiosis | 1 | 2021 | 53 | 0.190 |
Why?
|
Chromosome Deletion | 2 | 2018 | 1387 | 0.180 |
Why?
|
Pyrimidines | 4 | 2020 | 3016 | 0.170 |
Why?
|
Sulfonamides | 2 | 2021 | 1977 | 0.170 |
Why?
|
Leukemia, Prolymphocytic, B-Cell | 1 | 2019 | 1 | 0.170 |
Why?
|
Antigens, Neoplasm | 3 | 2017 | 1998 | 0.160 |
Why?
|
Cancer Vaccines | 3 | 2017 | 1046 | 0.160 |
Why?
|
Vinblastine | 1 | 2019 | 487 | 0.150 |
Why?
|
Humans | 54 | 2024 | 760621 | 0.150 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2019 | 146 | 0.140 |
Why?
|
Transplantation, Homologous | 5 | 2024 | 4810 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5253 | 0.140 |
Why?
|
Doxorubicin | 2 | 2024 | 2209 | 0.140 |
Why?
|
Dacarbazine | 1 | 2019 | 560 | 0.130 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2018 | 237 | 0.130 |
Why?
|
Quinoxalines | 1 | 2018 | 297 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9276 | 0.130 |
Why?
|
Signal Transduction | 3 | 2017 | 23376 | 0.130 |
Why?
|
Benzamides | 1 | 2021 | 1369 | 0.130 |
Why?
|
Azacitidine | 1 | 2017 | 334 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1199 | 0.130 |
Why?
|
Radioimmunotherapy | 1 | 2015 | 91 | 0.120 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2017 | 545 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2018 | 1493 | 0.120 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2017 | 646 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5643 | 0.110 |
Why?
|
Autoimmunity | 1 | 2021 | 1370 | 0.110 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2116 | 0.110 |
Why?
|
Aged | 18 | 2024 | 169152 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2017 | 10446 | 0.110 |
Why?
|
Cell Communication | 2 | 2017 | 1653 | 0.100 |
Why?
|
Treatment Failure | 2 | 2024 | 2648 | 0.100 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58995 | 0.100 |
Why?
|
Apoptosis | 4 | 2017 | 9501 | 0.100 |
Why?
|
Peptides | 2 | 2015 | 4354 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1895 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1378 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2919 | 0.090 |
Why?
|
Stromal Cells | 1 | 2017 | 1326 | 0.090 |
Why?
|
Middle Aged | 19 | 2024 | 220352 | 0.090 |
Why?
|
Bone Marrow | 2 | 2020 | 2912 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2017 | 8056 | 0.080 |
Why?
|
Platelet Count | 1 | 2012 | 777 | 0.080 |
Why?
|
Hemorrhage | 2 | 2020 | 3600 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2017 | 1342 | 0.080 |
Why?
|
Receptors, Interleukin-6 | 1 | 2010 | 226 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2017 | 3106 | 0.080 |
Why?
|
Standard of Care | 2 | 2022 | 552 | 0.080 |
Why?
|
Recurrence | 3 | 2022 | 8482 | 0.080 |
Why?
|
Anemia, Aplastic | 1 | 2010 | 228 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1268 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2017 | 2418 | 0.080 |
Why?
|
Adult | 14 | 2024 | 219994 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4550 | 0.070 |
Why?
|
Treatment Outcome | 11 | 2024 | 65017 | 0.070 |
Why?
|
Up-Regulation | 2 | 2017 | 4122 | 0.070 |
Why?
|
Thrombopoiesis | 1 | 2008 | 164 | 0.070 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 158 | 0.070 |
Why?
|
Antigen Presentation | 1 | 2012 | 1254 | 0.070 |
Why?
|
Thalidomide | 1 | 2012 | 884 | 0.070 |
Why?
|
Rheumatoid Factor | 1 | 1987 | 185 | 0.070 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1557 | 0.070 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5496 | 0.070 |
Why?
|
Female | 22 | 2024 | 391270 | 0.070 |
Why?
|
Survival Analysis | 4 | 2020 | 10182 | 0.060 |
Why?
|
Mice, SCID | 3 | 2016 | 2627 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1347 | 0.060 |
Why?
|
Male | 21 | 2024 | 359744 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4166 | 0.060 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2019 | 649 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39261 | 0.060 |
Why?
|
Europe | 1 | 2021 | 3441 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11152 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6828 | 0.060 |
Why?
|
MicroRNAs | 2 | 2017 | 3790 | 0.060 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 1007 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4897 | 0.060 |
Why?
|
Animals | 10 | 2020 | 167963 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6786 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2017 | 16939 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3584 | 0.050 |
Why?
|
Young Adult | 7 | 2024 | 58741 | 0.050 |
Why?
|
Bone Resorption | 1 | 1987 | 720 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 3075 | 0.050 |
Why?
|
Polydeoxyribonucleotides | 1 | 2023 | 138 | 0.050 |
Why?
|
Prognosis | 4 | 2020 | 29658 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4899 | 0.050 |
Why?
|
United States | 3 | 2023 | 72461 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1599 | 0.050 |
Why?
|
Vincristine | 1 | 2024 | 1039 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1907 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 201 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2015 | 1705 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2010 | 1588 | 0.050 |
Why?
|
Mutation | 3 | 2020 | 29932 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12808 | 0.040 |
Why?
|
Leukapheresis | 1 | 2020 | 134 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1660 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1837 | 0.040 |
Why?
|
Mice | 8 | 2020 | 81208 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 234 | 0.040 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2019 | 36 | 0.040 |
Why?
|
Chronic Disease | 3 | 2023 | 9287 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6465 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 335 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2138 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 928 | 0.040 |
Why?
|
Adolescent | 5 | 2024 | 87810 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1753 | 0.040 |
Why?
|
Cross-Priming | 1 | 2017 | 75 | 0.040 |
Why?
|
Perforin | 1 | 2017 | 167 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2018 | 384 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4573 | 0.040 |
Why?
|
Blotting, Western | 2 | 2015 | 5039 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2017 | 285 | 0.030 |
Why?
|
Cisplatin | 1 | 2022 | 1644 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 635 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2021 | 857 | 0.030 |
Why?
|
Safety | 1 | 2020 | 1148 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5799 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2234 | 0.030 |
Why?
|
Receptors, Antigen | 1 | 2015 | 51 | 0.030 |
Why?
|
Isoantigens | 1 | 2017 | 552 | 0.030 |
Why?
|
Hematologic Diseases | 1 | 2019 | 496 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 279 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 303 | 0.030 |
Why?
|
Dexamethasone | 1 | 2022 | 1927 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7343 | 0.030 |
Why?
|
Diarrhea | 1 | 2021 | 1319 | 0.030 |
Why?
|
NADP | 1 | 2015 | 223 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1832 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15840 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2016 | 172 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1351 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2015 | 5870 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3301 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 542 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 412 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1565 | 0.030 |
Why?
|
Immunomodulation | 1 | 2017 | 547 | 0.030 |
Why?
|
Incidence | 1 | 2021 | 21392 | 0.030 |
Why?
|
Glutathione | 1 | 2015 | 582 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 877 | 0.030 |
Why?
|
Drug Synergism | 1 | 2016 | 1754 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 1987 | 3763 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18416 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20509 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 995 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 798 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2222 | 0.020 |
Why?
|
Biological Products | 1 | 2020 | 916 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4035 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1755 | 0.020 |
Why?
|
Anemia | 1 | 2020 | 1511 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1612 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25942 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1513 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1827 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36060 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1135 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1647 | 0.020 |
Why?
|
Neoplasms | 2 | 2015 | 22072 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 12766 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 42063 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3157 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1649 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9280 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2145 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1871 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12531 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4490 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2017 | 11481 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4353 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6131 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2506 | 0.020 |
Why?
|
Benzoates | 1 | 2008 | 212 | 0.020 |
Why?
|
Hydrazines | 1 | 2008 | 224 | 0.020 |
Why?
|
Thrombopoietin | 1 | 2008 | 226 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8552 | 0.020 |
Why?
|
Arthrography | 1 | 1987 | 149 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 41335 | 0.020 |
Why?
|
Receptors, Fc | 1 | 2008 | 534 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2873 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3844 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2024 | 80372 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1810 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7588 | 0.010 |
Why?
|
Child | 1 | 2012 | 79806 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9585 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2250 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10756 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8515 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13308 | 0.010 |
Why?
|
Liver | 1 | 2016 | 7509 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3735 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40165 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6771 | 0.010 |
Why?
|
Hepatitis C | 1 | 2008 | 1579 | 0.010 |
Why?
|
Blood Platelets | 1 | 2008 | 2520 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22053 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11903 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 4938 | 0.010 |
Why?
|